Operating cash flow of -$302.7K against $5.4M in claims paid indicates that the company is failing to generate sufficient float to support its core medical service delivery.
| Cash from Operations | -4.34M | 2.51M | 2.6M | 2.79M |
| Operating CF Growth % | -273.12% | -3.49% | -6.89% | - |
| Operating CF / Revenue % | -38.38% | 24.97% | 26.8% | 26.2% |
| Net Income | -12.51M | 2.4M | 2.13M | 2.39M |
| Depreciation & Amortization | 1.18M | 528.73K | 557.13K | 575.92K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 10.23M | -419.19K | -375.51K | -251.26K |
| Working Capital Changes | -3.25M | -4.82K | 286.8K | 81.37K |
| Cash from Investing | -11.04M | -7.92K | -6.16K | -88.5K |
| Capital Expenditures | -54.76K | -7.92K | -6.16K | -88.5K |
| Acquisitions | -10.99M | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 |
| Other Investing | 0 | 0 | 0 | 0 |
| Cash from Financing | 16.91M | -1.77M | -2.94M | -12.92M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 |
| Stock Issued | 9.75M | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K |
| Other Financing | 12.34M | 1.16M | 325 | -10.86M |
| Net Change in Cash | 1.03M | 733.61K | -346.24K | -10.22M |
| Exchange Rate Effect | -495.74K | 0 | 0 | 0 |
| Cash at Beginning | 1.95M | 1.22M | 1.56M | 11.78M |
| Cash at End | 2.98M | 1.95M | 1.22M | 1.56M |
| Free Cash Flow | -4.4M | 2.5M | 2.59M | 2.7M |
| FCF Growth % | -275.86% | -3.56% | -4.07% | - |
| FCF Margin % | -38.86% | 24.89% | 26.74% | 25.37% |
| FCF per Share | -2.81 | 1.85 | 1.92 | 2 |
Unsustainable Cash Burn Rate
As reported in the 2024Q4 financial statements, BMGL generated an operating cash flow of -$302.7K against $5.4M in claims paid, indicating that the company is currently unable to leverage premium float to offset its operational expenses or fund its ongoing medical service delivery requirements.
The negative operating cash flow suggests that the company is effectively subsidizing its claims payments with external capital rather than internal premium generation. This dynamic implies that the current underwriting model is not yet self-sustaining, as the cash outflow for claims exceeds the net cash inflow from premiums.
Based on the 2024Q4 data, the company reported a net loss of $9.9M while maintaining a cash burn of $302.7K, which suggests that significant non-cash accruals or accounting adjustments are masking the true severity of the company's underlying cash-based operational deficit.
The wide gap between the net loss and the operating cash flow warrants further investigation into the nature of these accruals, as they may represent non-cash charges that do not reflect the actual liquidity pressure. Investors should monitor whether these adjustments are temporary accounting artifacts or indicative of structural issues in revenue recognition.
According to the latest quarterly figures, the company's cash position of $2.9M appears insufficient to cover the current burn rate, suggesting that BMGL may face significant liquidity risks if it cannot rapidly achieve operating leverage or secure additional financing to support its ongoing expansion.
The reliance on external funding to bridge the gap between claims payments and premium receipts indicates a vulnerable balance sheet position. This situation implies that the company's ability to continue its current growth trajectory is highly dependent on capital market conditions rather than internal cash generation.
Quick answers to the most common questions about buying BMGL stock.
Basel Medical Group Ltd Ordinary Shares (BMGL) generated $-4.3M in net cash from operating activities in 2024. This reflects the cash generated directly from core business operations.
Basel Medical Group Ltd Ordinary Shares (BMGL) reported negative free cash flow of $4.4M in 2024, indicating capital requirements exceeded cash from operations.
Basel Medical Group Ltd Ordinary Shares (BMGL) spent $0.1M on capital expenditures in 2024. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.